Samantha Haeberlein
Director/Board Member chez VIGIL NEUROSCIENCE, INC.
Fortune : - $ au 31/03/2024
Profil
Samantha Budd Haeberlein is currently the Director at The Boston Home.
She also holds current positions as an Independent Director at Vigil Neuroscience, Inc. and as a Senior Advisor at Intermediate Capital Group Plc (Private Equity).
In the past, she worked as a Director at Rodin Therapeutics, Inc. in 2016 and as the Vice President-Clinical Development at Biogen, Inc. from 2015 to 2020.
Dr. Haeberlein received her undergraduate and doctorate degrees from the University of Dundee.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VIGIL NEUROSCIENCE, INC.
-.--% | 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Samantha Haeberlein
| Sociétés | Poste | Début |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Director/Board Member | 08/05/2023 |
The Boston Home
 The Boston Home Medical/Nursing ServicesHealth Services The Boston Home serves adults with multiple sclerosis and other progressive neurological diseases. It offers wheelchair enhancement centre, B fit day program and rehabilitation services. The company was founded in 1881 and is headquartered in Boston, MA. | Director/Board Member | - |
Intermediate Capital Group Plc (Private Equity)
 Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom. | Consultant / Advisor | 01/09/2023 |
Anciens postes connus de Samantha Haeberlein
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2020 |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA. | Director/Board Member | 01/12/2016 |
Formation de Samantha Haeberlein
| University Of Dundee | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Intermediate Capital Group Plc (Private Equity)
Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom. | Finance |
The Boston Home
The Boston Home Medical/Nursing ServicesHealth Services The Boston Home serves adults with multiple sclerosis and other progressive neurological diseases. It offers wheelchair enhancement centre, B fit day program and rehabilitation services. The company was founded in 1881 and is headquartered in Boston, MA. | Health Services |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA. | Health Technology |
